CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 45 target
Drug / intervention
Electroencephalogram (EEG)other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06389721
NCT06389721N/ARecruitingOn Track
CompareCT.gov

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

M.D. Anderson Cancer Center·observational·Posted Apr 29, 2024·Updated May 19, 2026

In Brief

An observational study evaluating Electroencephalogram (EEG) for Chemotherapy-induced Peripheral Neuropathy. Currently recruiting, targeting 45 participants across 1 site.

Detailed Summary

Cohort 1: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN). Cohort 2: To track the onset and progression of a condition called chemotherapy-induced peripheral neuropathy (CIPN) and to test a certain type of experimental neuromodulation (stimulation of the brain) with a device called a closed-loop brain-computer interface (clBCI) to see if can help to prevent pain due to CIPN.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsChemotherapy-induced Peripheral Neuropathy
CountriesUnited States
Collaborators--

Timeline

N/ARecruiting
202520262027
First PostedApr 29, 2024
Enrollment StartJul 16, 2024
Primary CompletionJan 31, 2027
TodayJul 1, 2026
Enrollment to primary: 2.5 yearsPosted 2.2 years agoPrimary completion in 7 months

Interventions

Electroencephalogram (EEG)other

Measure the electrical activity of your brain before you receive chemotherapy treatment and once monthly for a maximum of 6 measurements.